| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Pre-Release |
| Funding Opportunity Posted By | DOW |
| Component | DHA - CDMRP |
| Funding Opportunity Title | Parkinson’s Research Program |
| Link to Funding Opportunity | health.mil |
| Funding Opportunity Short Description | To support innovative, high-impact research with clinical relevance that will decrease risk, slow progression, or ease symptoms of Parkinson's disease. |
| Funding Opportunity Category | Health and Biomedical Technologies |
| Important Dates | |
| Funding Details | |
| Required Registrations |
|
| Funding Opportunity Full Description | Two Award Mechanisms (1) Early Investigator Research Award (2) Investigator-Initiated Research Award The FY26 Defense Appropriations Act provides funding for the PRP to support innovative, high-impact research with clinical relevance that will decrease risk, slow progression, or ease symptoms of Parkinson's disease. As part of the DHA R&D-MRDC, the CDMRP is the program office managing these anticipated FY26 funding opportunities. The PRP provides the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunities. Investigators should not construe this pre-announcement as an obligation or promise by the government. The CDMRP will post FY26 PRP funding opportunity announcements on the Grants.gov website. Once released, the funding opportunity announcements will include pre-application and application deadlines. Applications submitted to the FY26 PRP must address one or more of the following focus areas: Understanding how Parkinson's disease biological and clinical heterogeneity impacts disease presentation, clinical course and therapeutic outcomes, from prodromal to late-stage Parkinson's disease |
